News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
First-line management of ALK-positive NSCLC with CNS metastases – Florez Lab
Jul 25, 2024, 00:44

First-line management of ALK-positive NSCLC with CNS metastases – Florez Lab

Florez Lab shared on X:

“Dr. Narjust Florez joins Drs. Todd Bauer and Sai-Hong Ou in an ASCO Post Video Roundtable discussing first-line management of ALK-positive NSCLC with CNS metastases.

Don’t miss this insightful discussion! Watch now.”

Florez Lab

Source: Florez Lab/X

ASCO Post cancer Florez Lab Narjust Florez NSCLC OncoDaily Oncology Sai-Hong Ou Todd Bauer
Special Coverage
Opinion
Apr 2, 2025, 07:50
Eric Singhi: How MARIPOSA and MARIPOSA-2 studies differ
Blog
Apr 2, 2025, 07:46
Roupen Odabashian: Biggest mistakes healthcare founders make
Blog
Apr 2, 2025, 07:35
50 % of men will have a rising PSA after prostatectomy for Prostate Cancer - ASCO
Blog
Apr 2, 2025, 07:19
Structural insights into human topoisomerase 3β DNA and RNA catalysis and nucleic acid gate dynamics
Blog
Apr 2, 2025, 07:12
Amol Akhade Seeks Expert Opinions on EV Plus Pembro Dosing for High-Risk Patients
Insight
Apr 2, 2025, 06:49
New Treatment Option for Platinum-Resistant Ovarian Cancer - ENGOT
Blog
Apr 2, 2025, 06:39
Norman Ng: The Journey of the respiratory syncytial virus vaccine
Celebrities
Apr 2, 2025, 05:50
Val Kilmer Dies at 65: The Actor Who Fought Throat Cancer and Inspired Generations
Blog
Apr 2, 2025, 05:44
Cancer care in Phnom Penh is evolving through collaboration, commitment, and action - City Cancer Challenge
Blog
Apr 2, 2025, 05:21
Barbara Ewals: The Power of SDG Partnerships - A Decisive Factor in Achieving the 2030 Agenda
Blog
Apr 2, 2025, 04:28
Ioana Stoenescu: A Call to Action for More Effective Oncology Care Financing in Romania
Blog
Apr 2, 2025, 03:29
Celebrating an Expert in Oncology: Dr. Joyce A. O'Shaughnessy - Sarah Cannon Research Institute